YUM Insider Filing: 7,788 SARs Granted; CEO Discloses Trades
Rhea-AI Filing Summary
YUM Brands (YUM) Insider Report: This Form 4 shows David W. Gibbs, CEO and Director, made multiple transactions on 09/15/2025 under a Rule 10b5-1 plan. He acquired 7,788 stock appreciation rights (SARs) with a grant price of $49.66 and 3,184 SARs at $56.67. Several common-stock transactions occurred the same day: acquisitions and dispositions that net to 102,893.15 shares beneficially owned after the transactions. Some shares are held indirectly: 72,499 by spouse and 48,394 in a Trust (SJG). The SARs vest 25% per year beginning one year from grant and have various exercisability and expiration dates, with underlying common stock amounts disclosed.
Positive
- Transactions executed under a Rule 10b5-1 plan, which provides an affirmative defense against insider trading claims
- Clear disclosure of indirect holdings (72,499 by spouse; 48,394 in Trust SJG), improving transparency
- SARs include a defined vesting schedule (25% per year), aligning long-term incentives
Negative
- Insider sold shares on the same day as grants, which could raise short-term attention despite being under a 10b5-1 plan
- Filing does not state aggregate dollar values of sales/purchases, limiting assessment of magnitude
Insights
TL;DR: CEO executed mixed option grants and stock trades under a 10b5-1 plan; transactions appear procedural, not an extraordinary event.
The filing documents a combination of stock appreciation right grants and contemporaneous open-market activity executed pursuant to a 10b5-1 plan. The SAR grants have explicit exercise/expiration timing and a standard vesting schedule (25% per year). Indirect holdings via spouse and trust are disclosed, increasing transparency about total beneficial ownership. From a governance standpoint, the use of a documented trading plan reduces insider-trading risk and signals pre-arranged execution rather than opportunistic timing.
TL;DR: Transactions include grant of SARs and stock trades; material impact on supply or valuation is not evident from this single filing.
The report lists SAR grants (7,788 and 3,184 SARs) and several purchases/sales of common stock at reported prices between $49.66 and $149.80. The filing does not present proceeds, total dollar value aggregated, or company-level metrics, so market impact cannot be measured here. Reported indirect holdings (spouse and trust) should be combined with direct holdings when assessing total insider ownership.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Appreciation Right | 7,788 | $0.00 | -- |
| Exercise | Stock Appreciation Right | 3,184 | $0.00 | -- |
| Exercise | Common Stock | 7,788 | $49.66 | $387K |
| Disposition | Common Stock | 2,588 | $149.49 | $387K |
| Sale | Common Stock | 5,200 | $149.80 | $779K |
| Exercise | Common Stock | 3,184 | $56.67 | $180K |
| Disposition | Common Stock | 1,208 | $149.49 | $181K |
| Sale | Common Stock | 1,976 | $149.80 | $296K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Pursuant to 10b5-1 Plan Vesting occurs 25% per year beginning one year from grant date.
